NEW YORK, March 19, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Entravision Communications Corp. (“Entravision” or the “Company”) (NYSE: EVC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980….
Month: March 2024
NEW YORK, March 19, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Entravision Communications Corp. (“Entravision” or the “Company”) (NYSE: EVC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980….
DUBLIN, March 19, 2024 /PRNewswire/ — The “Manufacturing Execution System in Life Sciences Market Size, Share & Trends Analysis Report By Solution Type, By Deployment (On-Premise, Cloud/Web-Based, Hybrid), By End-User, By Region, And Segment Forecasts, 2024 – 2030” report has been added…
DUBLIN, March 19, 2024 /PRNewswire/ — The “Manufacturing Execution System in Life Sciences Market Size, Share & Trends Analysis Report By Solution Type, By Deployment (On-Premise, Cloud/Web-Based, Hybrid), By End-User, By Region, And Segment Forecasts, 2024 – 2030” report has been added…
NEW YORK, March 19, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Grifols S.A. (“Grifols” or the “Company”) (NASDAQ: GRFS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, March 19, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Grifols S.A. (“Grifols” or the “Company”) (NASDAQ: GRFS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, March 19, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Sonder Holdings Inc. (“Sonder” or the “Company”) (NASDAQ: SOND). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, March 19, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Sonder Holdings Inc. (“Sonder” or the “Company”) (NASDAQ: SOND). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, March 19, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Vanda Pharmaceutical Inc. (“Vanda” or the “Company”) (NASDAQ: VNDA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, March 19, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Vanda Pharmaceutical Inc. (“Vanda” or the “Company”) (NASDAQ: VNDA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…